SmithKline in radical shake-up

THE DRUGS to Ribena giant SmithKline Beecham yesterday stunned the City with radical plans to cut its workforce by more than a quarter, to focus on its core pharmaceuticals and healthcare businesses.

The company announced the disposal of two underperforming US businesses for over $2bn and the closure or sale of several of its manufacturing plants. The sweeping restructuring will see the departure of around 15,000 of SB's 58,000 employees over the next four years. The measures will land SB with an exceptional charge of over pounds 1bn but the company said they would help to reduce costs and boost profits in the long term.

SB used the announcement to rush out its 1998 results. The figures, released a week earlier than expected, showed a 10 per cent rise in underlying profits to pounds 1.77bn on sales up 7 per cent to pounds 8.3bn.

The chief executive, Jan Leschly, denied suggestions that the shake-up could rekindle a pounds 120bn mega-merger with SB's UK arch-rival Glaxo Wellcome. Talks between the two companies foundered last year after a clash of personalities between Mr Leschly and the Glaxo chairman Sir Richard Sykes. "This has nothing to do with the previous discussions we had on a merger. We think we'll be an independent company now, a stronger company," Mr Leschly said.

He said SB's leaner structure would help to boost earnings by around 13 per cent this year and to produce "mid to high teens growth in 2000 and 2001". Mr Leschly said the restructuring would free up resources for new pharmaceutical products such as the forthcoming blockbuster Avandia, a diabetes drug with expected sales of over $1bn.

Money will also be invested in SB's consumer products, which include Ribena, Lucozade and Aquafresh. SB shares finished 33p higher at 831.5p as dealers welcomed the plans and refused to believe Mr Leschly's denial of merger talks.

SB declined to specify which of its manufacturing plants would close but a spokesman said that there would be few redundancies among UK-based staff. SB employs around 4,000 people at factories at Irvine in Scotland and Crawley and Worthing, both in Sussex. The scale-down in manufacturing and a renegotiation of deals with suppliers will lead to cost savings of pounds 200m a year from 2002. Before then, SB will take a pounds 750m restructuring charge, with pounds 90m already included in this year's accounts.

In a marked shift from the expansionist strategy of the past few years, SB also announced the disposal of two US businesses employing 15,000 people. Clinical Laboratories, a US-based clinical trials unit, was sold to rival Quest Diagnostics for $1bn in cash - well below the $2.3bn paid by SB to acquire the business - and a 29.5 per cent stake in the enlarged group.

DPS, an agency which manages health benefits for 23 million Americans, went to US rival Express Scripts for $700m in cash and a $300m tax benefit. SB said it took a pounds 629m provision for the loss on the DPS operations.The proceeds will go to cutting SB's debt, with gearing set to fall to around 15 per cent from 52 per cent in 1998.

Start your day with The Independent, sign up for daily news emails
News
ebooksAn unforgettable anthology of contemporary reportage
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Digital Optimisation Executive - Marketing

£30000 - £35000 per annum: Recruitment Genius: The UK's fastest growing, multi...

Recruitment Genius: Financial Reporting Manager

£70000 - £90000 per annum: Recruitment Genius: A Financial Reporting Manager i...

Recruitment Genius: Payments Operations Assistant

£23000 - £25000 per annum: Recruitment Genius: They win lots of awards for the...

Recruitment Genius: Telephone Debt Negotiator

£13500 - £20000 per annum: Recruitment Genius: This nationwide enforcement com...

Day In a Page

Sepp Blatter resignation: The beginning of Fifa's long road to reform?

Does Blatter's departure mean Fifa will automatically clean up its act?

Don't bet on it, says Tom Peck
Charles Kennedy: The baby of the House who grew into a Lib Dem giant

The baby of the House who grew into a Lib Dem giant

Charles Kennedy was consistently a man of the centre-left, dedicated to social justice, but was also a champion of liberty and an opponent of the nanny-state, says Baroness Williams
Syria civil war: The harrowing testament of a five-year-old victim of this endless conflict

The harrowing testament of a five-year-old victim of Syria's endless civil war

Sahar Qanbar lost her mother and brother as civilians and government soldiers fought side by side after being surrounded by brutal Islamist fighters. Robert Fisk visited her
The future of songwriting: How streaming is changing everything we know about making music

The future of songwriting

How streaming is changing everything we know about making music
William Shemin and Henry Johnson: Jewish and black soldiers receive World War I Medal of Honor amid claims of discrimination

Recognition at long last

Jewish and black soldiers who fought in WWI finally receive medals after claims of discrimination
Beating obesity: The new pacemaker which helps over-eaters

Beating obesity

The new pacemaker which helps over-eaters
9 best women's festival waterproofs

Ready for rain: 9 best women's festival waterproofs

These are the macs to keep your denim dry and your hair frizz-free(ish)
Cycling World Hour Record: Nervous Sir Bradley Wiggins ready for pain as he prepares to go distance

Wiggins worried

Nervous Sir Bradley ready for pain as he prepares to attempt cycling's World Hour Record
Liverpool close in on Milner signing

Liverpool close in on Milner signing

Reds baulk at Christian Benteke £32.5m release clause
On your feet! Spending at least two hours a day standing reduces the risk of heart attacks, cancer and diabetes, according to new research

On your feet!

Spending half the day standing 'reduces risk of heart attacks and cancer'
With scores of surgeries closing, what hope is there for the David Cameron's promise of 5,000 more GPs and a 24/7 NHS?

The big NHS question

Why are there so few new GPs when so many want to study medicine?
Big knickers are back: Thongs ain't what they used to be

Thongs ain't what they used to be

Big knickers are back
Thurston Moore interview

Thurston Moore interview

On living in London, Sonic Youth and musical memoirs
In full bloom

In full bloom

Floral print womenswear
From leading man to Elephant Man, Bradley Cooper is terrific

From leading man to Elephant Man

Bradley Cooper is terrific